Anti-Human CD20 Recombinant Antibody(Ocaratuzumab)
-
产品编号
YR1285
-
别名
科研级 Ocaratuzumab ( 奥卡妥珠单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Ocaratuzumab ( 奥卡妥珠单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocaratuzumab |
Catalog Number | YR1285 |
Molecular Name | Ocaratuzumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Ocaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity (ADCC), and for improved treatment of low-affinity FcγRIIIa allotypes. |
CAS Number | 1169956-08-4 |
Application | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CD20[Homo sapiens] |